Related Experiment Videos
c-K-ras mutations in human carcinomas occur preferentially in codon 12
L Yanez1, J Groffen, D M Valenzuela
1Oncogene Science, Inc., Manhasset, New York 11030.
Oncogene
|January 1, 1987
Summary
This study investigated mutations in the c-K-ras gene in human carcinomas. Codon 12 mutations were found in colon, lung, and breast cancers, but not at codon 61.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The c-K-ras gene is frequently implicated in human carcinogenesis.
- Understanding ras gene mutations is crucial for targeted cancer therapies.
Purpose of the Study:
- To determine the frequency and distribution of c-K-ras gene mutations.
- To analyze mutations specifically in codons 12 and 61 of the c-K-ras gene in various human carcinomas.
Main Methods:
- Analysis of 51 human carcinoma samples (lung, colon, breast).
- Utilized oligonucleotide panels to detect wild-type and mutant forms of c-K-ras codons 12 and 61.
Main Results:
- Mutations in c-K-ras codon 12 were identified in 4/16 colon, 2/27 lung, and 1/8 breast carcinomas.
- No mutations were detected in codon 61 across all analyzed samples.
- Seven distinct codon 12 mutations were found, representing all but one possible amino acid change.
Conclusions:
- c-K-ras codon 12 mutations are present in a subset of human lung, colon, and breast carcinomas.
- The absence of codon 61 mutations suggests specific mutational patterns in these cancer types.
- The identified mutations provide insights into oncogenic pathways and potential therapeutic targets.